Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Gene regulation and tumor suppression by the bromodomain-containing protein BRD7.

Mantovani F, Drost J, Voorhoeve PM, Del Sal G, Agami R.

Cell Cycle. 2010 Jul 15;9(14):2777-81. Epub 2010 Jul 7.

PMID:
20647772
[PubMed - indexed for MEDLINE]
Free Article
2.

BRD7 is a candidate tumour suppressor gene required for p53 function.

Drost J, Mantovani F, Tocco F, Elkon R, Comel A, Holstege H, Kerkhoven R, Jonkers J, Voorhoeve PM, Agami R, Del Sal G.

Nat Cell Biol. 2010 Apr;12(4):380-9. doi: 10.1038/ncb2038. Epub 2010 Mar 14.

PMID:
20228809
[PubMed - indexed for MEDLINE]
3.

Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence.

Burrows AE, Smogorzewska A, Elledge SJ.

Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14280-5. doi: 10.1073/pnas.1009559107. Epub 2010 Jul 26.

PMID:
20660729
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.

Peng C, Zhou J, Liu HY, Zhou M, Wang LL, Zhang QH, Yang YX, Xiong W, Shen SR, Li XL, Li GY.

J Cell Biochem. 2006 Mar 1;97(4):882-92.

PMID:
16265664
[PubMed - indexed for MEDLINE]
5.

Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.

Nourani A, Doyon Y, Utley RT, Allard S, Lane WS, Côté J.

Mol Cell Biol. 2001 Nov;21(22):7629-40.

PMID:
11604499
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes.

Sun J, Nie J, Hao B, Li L, Xing G, Wang Z, Zhou Y, Sun Q, Li G, Zhang L, He F.

Cell Signal. 2008 Jun;20(6):1151-8. doi: 10.1016/j.cellsig.2008.02.002. Epub 2008 Feb 12.

PMID:
18329849
[PubMed - indexed for MEDLINE]
7.

BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.

Zhou J, Ma J, Zhang BC, Li XL, Shen SR, Zhu SG, Xiong W, Liu HY, Huang H, Zhou M, Li GY.

J Cell Physiol. 2004 Jul;200(1):89-98.

PMID:
15137061
[PubMed - indexed for MEDLINE]
8.

ING1 represses transcription by direct DNA binding and through effects on p53.

Kataoka H, Bonnefin P, Vieyra D, Feng X, Hara Y, Miura Y, Joh T, Nakabayashi H, Vaziri H, Harris CC, Riabowol K.

Cancer Res. 2003 Sep 15;63(18):5785-92.

PMID:
14522900
[PubMed - indexed for MEDLINE]
Free Article
9.

Activated p53 suppresses the histone methyltransferase EZH2 gene.

Tang X, Milyavsky M, Shats I, Erez N, Goldfinger N, Rotter V.

Oncogene. 2004 Jul 29;23(34):5759-69.

PMID:
15208672
[PubMed - indexed for MEDLINE]
10.

Human Spot 14 protein is a p53-dependent transcriptional coactivator via the recruitment of thyroid receptor and Zac1.

Chou WY, Ho CL, Tseng ML, Liu ST, Yen LC, Huang SM.

Int J Biochem Cell Biol. 2008;40(9):1826-34. doi: 10.1016/j.biocel.2008.01.014. Epub 2008 Jan 20.

PMID:
18299245
[PubMed - indexed for MEDLINE]
11.
12.

Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.

Herzer K, Weyer S, Krammer PH, Galle PR, Hofmann TG.

Cancer Res. 2005 Dec 1;65(23):10830-7.

PMID:
16322229
[PubMed - indexed for MEDLINE]
Free Article
13.

Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling.

Hubackova S, Novakova Z, Krejcikova K, Kosar M, Dobrovolna J, Duskova P, Hanzlikova H, Vancurova M, Barath P, Bartek J, Hodny Z.

Cell Cycle. 2010 Aug 1;9(15):3085-99. doi: 10.4161/cc.9.15.12521. Epub 2010 Aug 26.

PMID:
20699642
[PubMed - indexed for MEDLINE]
Free Article
14.

PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.

Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP, Pelicci PG.

Nature. 2000 Jul 13;406(6792):207-10.

PMID:
10910364
[PubMed - indexed for MEDLINE]
15.

Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression.

Uramoto H, Izumi H, Nagatani G, Ohmori H, Nagasue N, Ise T, Yoshida T, Yasumoto K, Kohno K.

Biochem J. 2003 Apr 15;371(Pt 2):301-10.

PMID:
12534345
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions.

Wise-Draper TM, Allen HV, Jones EE, Habash KB, Matsuo H, Wells SI.

Mol Cell Biol. 2006 Oct;26(20):7506-19. Epub 2006 Aug 7.

PMID:
16894028
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding.

Gomes NP, Espinosa JM.

Genes Dev. 2010 May 15;24(10):1022-34. doi: 10.1101/gad.1881010.

PMID:
20478995
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Senescence evasion by MCF-7 human breast tumor-initiating cells.

Karimi-Busheri F, Rasouli-Nia A, Mackey JR, Weinfeld M.

Breast Cancer Res. 2010;12(3):R31. doi: 10.1186/bcr2583. Epub 2010 Jun 2.

PMID:
20525204
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

p53-Dependent and -independent functions of the Arf tumor suppressor.

Sherr CJ, Bertwistle D, DEN Besten W, Kuo ML, Sugimoto M, Tago K, Williams RT, Zindy F, Roussel MF.

Cold Spring Harb Symp Quant Biol. 2005;70:129-37. Review.

PMID:
16869746
[PubMed - indexed for MEDLINE]
20.

TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor.

Spiesbach K, Tannapfel A, Mössner J, Engeland K.

Int J Cancer. 2005 Apr 20;114(4):555-62.

PMID:
15578720
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk